165 related articles for article (PubMed ID: 37656292)
21. Molecular interactions in juvenile nasopharyngeal angiofibroma: preliminary signature and relevant review.
Mishra A; Jaiswal R; Amita P; Mishra SC
Eur Arch Otorhinolaryngol; 2019 Jan; 276(1):93-100. PubMed ID: 30387011
[TBL] [Abstract][Full Text] [Related]
22. Clinical correlation of molecular (VEGF, FGF, PDGF, c-Myc, c-Kit, Ras, p53) expression in juvenile nasopharyngeal angiofibroma.
Mishra A; Mishra SC; Tripathi AM; Pandey A
Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2719-2726. PubMed ID: 30171340
[TBL] [Abstract][Full Text] [Related]
23. Stem cell-related proteins C-KIT, C-MYC and BMI-1 in juvenile nasopharyngeal angiofibroma--do they have a role?
Renkonen S; Häyry V; Heikkilä P; Leivo I; Haglund C; Mäkitie AA; Hagström J
Virchows Arch; 2011 Feb; 458(2):189-95. PubMed ID: 21113618
[TBL] [Abstract][Full Text] [Related]
24. Molecular pathogenesis of juvenile nasopharyngeal angiofibroma in brazilian patients.
Maniglia MP; Ribeiro ME; Costa NM; Jacomini ML; Carvalho TB; Molina FD; Piatto VB; Maniglia JV
Pediatr Hematol Oncol; 2013 Oct; 30(7):616-22. PubMed ID: 23802802
[TBL] [Abstract][Full Text] [Related]
25. Aromatase may play a critical role in the pathogenesis of juvenile nasopharyngeal angiofibroma.
Schlauder SM; Knapp C; Steffensen TS; Bui MM
Fetal Pediatr Pathol; 2009; 28(5):232-8. PubMed ID: 19842877
[TBL] [Abstract][Full Text] [Related]
26. Relaxation of imprinting of IGFII gene in juvenile nasopharyngeal angiofibromas.
Coutinho-Camillo CM; Brentani MM; Butugan O; Torloni H; Nagai MA
Diagn Mol Pathol; 2003 Mar; 12(1):57-62. PubMed ID: 12605037
[TBL] [Abstract][Full Text] [Related]
27. Juvenile nasopharyngeal angiofibroma staging: An overview.
Alshaikh NA; Eleftheriadou A
Ear Nose Throat J; 2015 Jun; 94(6):E12-22. PubMed ID: 26053985
[TBL] [Abstract][Full Text] [Related]
28.
Sakthivel P; Kumar R; Arunraj ST; Bhalla AS; Prashanth A; Kumar R; Sharma SC; Thakar A
Laryngoscope; 2021 Jul; 131(7):1509-1515. PubMed ID: 33355921
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical analysis of growth mechanisms in juvenile nasopharyngeal angiofibroma.
Schuon R; Brieger J; Heinrich UR; Roth Y; Szyfter W; Mann WJ
Eur Arch Otorhinolaryngol; 2007 Apr; 264(4):389-94. PubMed ID: 17177025
[TBL] [Abstract][Full Text] [Related]
30. Systems-level analysis of clinically different phenotypes of juvenile nasopharyngeal angiofibromas.
Renkonen S; Kankainen M; Hagström J; Haglund C; Monni O; Mäkitie AA
Laryngoscope; 2012 Dec; 122(12):2728-35. PubMed ID: 22965421
[TBL] [Abstract][Full Text] [Related]
31. Identification of Heat Shock Protein 90 as a Recurrence Related Marker in Juvenile Nasopharyngeal Angiofibroma.
Wang J; Hu L; Liu Z; Wang H; Zhang H; Song X; Sun X; Wang D
Am J Rhinol Allergy; 2022 Jan; 36(1):8-17. PubMed ID: 33940949
[TBL] [Abstract][Full Text] [Related]
32. Juvenile nasopharyngeal angiofibroma: no evidence for inheritance or association with familial adenomatous polyposis.
Klockars T; Renkonen S; Leivo I; Hagström J; Mäkitie AA
Fam Cancer; 2010 Sep; 9(3):401-3. PubMed ID: 20229070
[TBL] [Abstract][Full Text] [Related]
33. (99m)TC-octreotide scintigraphy and somatostatin receptor subtype expression in juvenile nasopharyngeal angiofibromas.
Kukwa W; Andrysiak R; Kukwa A; Hubalewska-Dydejczyk A; Gronkiewicz Z; Wojtowicz P; Krolicki L; Wierzchowski W; Grochowski T; Czarnecka AM
Head Neck; 2011 Dec; 33(12):1739-46. PubMed ID: 22076978
[TBL] [Abstract][Full Text] [Related]
34. Preoperative emobilisation of juvenile nasopharyngeal angiofibroma.
Meher R; Kathuria S; Wadhwa V; Ali MR; Shah B; Bansal A; Goel P
Am J Otolaryngol; 2022; 43(5):103532. PubMed ID: 35714497
[TBL] [Abstract][Full Text] [Related]
35. Human Papilloma virus in Juvenile Nasopharyngeal Angiofibroma: possible recent trend.
Mishra A; Sachadeva M; Jain A; Shukla NM; Pandey A
Am J Otolaryngol; 2016; 37(4):317-22. PubMed ID: 27157983
[TBL] [Abstract][Full Text] [Related]
36. Switch in FGFR3 and -4 expression profile during human renal development may account for transient hypercalcemia in patients with Sotos syndrome due to 5q35 microdeletions.
Mutsaers HA; Levtchenko EN; Martinerie L; Pertijs JC; Allegaert K; Devriendt K; Masereeuw R; Monnens LA; Lombès M
J Clin Endocrinol Metab; 2014 Jul; 99(7):E1361-7. PubMed ID: 24670087
[TBL] [Abstract][Full Text] [Related]
37. Recurrent FGFR3-TACC3 fusion gene in nasopharyngeal carcinoma.
Yuan L; Liu ZH; Lin ZR; Xu LH; Zhong Q; Zeng MS
Cancer Biol Ther; 2014; 15(12):1613-21. PubMed ID: 25535896
[TBL] [Abstract][Full Text] [Related]
38. The risk factors for residual juvenile nasopharyngeal angiofibroma and the usual residual sites.
Liu Z; Hua W; Zhang H; Wang J; Song X; Hu L; Lu H; Wang D
Am J Otolaryngol; 2019; 40(3):343-346. PubMed ID: 30885446
[TBL] [Abstract][Full Text] [Related]
39. Nasopharyngeal Angiofibroma Staging with a Novel Nominal Basis: An 18-Year Study in a Tertiary Center.
Abdelwahab M; Overdevest JB; Elmokadem A; El-Sisi H; El-Kholy NA; Zaki H; Kamal E; Khafagy Y; Tawfik A; Eldawoody H; Hwang P; Rakha A
Otolaryngol Head Neck Surg; 2019 Aug; 161(2):352-361. PubMed ID: 31012381
[TBL] [Abstract][Full Text] [Related]
40. The site of origin and expansive routes of juvenile nasopharyngeal angiofibroma (JNA).
Liu ZF; Wang DH; Sun XC; Wang JJ; Hu L; Li H; Dai PD
Int J Pediatr Otorhinolaryngol; 2011 Sep; 75(9):1088-92. PubMed ID: 21719122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
